Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

histoplasmosis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report highlights secondary hemophagocytic lymphohistiocytosis in an immunocompetent adult, emphasizing the need to differentiate between sarcoidosis and histoplasmosis. This research contributes to the understanding of complex presentations in rare diseases.

A case study highlights the delayed diagnosis of primary cutaneous histoplasmosis in a patient undergoing tumor necrosis factor alpha inhibitor therapy. This underscores the need for heightened awareness of rare infections in immunocompromised patients.

A recent study highlights a case of histoplasmosis-associated hemophagocytic lymphohistiocytosis presenting as pyrexia of unknown origin with splenic masses. This research contributes to the understanding of rare disease manifestations and their clinical implications.

Not rare diseases news,news about your rare disease.

Earlier

A case report highlights secondary hemophagocytic lymphohistiocytosis in an immunocompetent adult, emphasizing the need to differentiate between sarcoidosis and histoplasmosis. This research contributes to the understanding of complex presentations in rare diseases.

A case study highlights the delayed diagnosis of primary cutaneous histoplasmosis in a patient undergoing tumor necrosis factor alpha inhibitor therapy. This underscores the need for heightened awareness of rare infections in immunocompromised patients.

A recent study highlights a case of histoplasmosis-associated hemophagocytic lymphohistiocytosis presenting as pyrexia of unknown origin with splenic masses. This research contributes to the understanding of rare disease manifestations and their clinical implications.

Not rare diseases news,
news about your rare disease.